Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7243)
All Articles published online
|
Publishing Process of This Article
|
Jun 21, 2019 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fan WD, Chen T, Liu PJ. NIMA related kinase 2 promotes gastric cancer cell proliferation via ERK/MAPK signaling. World J Gastroenterol 2019; 25(23): 2898-2910 [PMID: 31249448 DOI: 10.3748/wjg.v25.i23.2898] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i23/2898.htm |
| Number | Citing Articles |
| 1 |
Yun-Qiang Zhang, Kai Li, Qiang Guo, Dan Li. A New Risk Model Based on 7 Quercetin-Related Target Genes for Predicting the Prognosis of Patients With Lung Adenocarcinoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.890079
|
| 2 |
Jiliang Xia, Hongyan Zhao, Jacob L. Edmondson, Brian Koss, Fenghuang Zhan. Role of NEK2 in tumorigenesis and tumor progression. Trends in Molecular Medicine 2024; doi: 10.1016/j.molmed.2024.07.013
|
| 3 |
Jiao Yang, Yuhua Hu, Jianliang Wu, Shiqi Kong. Effects of IGFBP-3 and GalNAc-T14 on proliferation and cell cycle of glioblastoma cells and its mechanism. Journal of Pharmacy and Pharmacology 2020; 72(2): 218 doi: 10.1111/jphp.13187
|
| 4 |
Huihui Hu, Hangdi Xu, Fen Lu, Jisong Zhang, Li Xu, Shan Xu, Hanliang Jiang, Qingxin Zeng, Enguo Chen, Zhengfu He. RETRACTED: Exosome-Derived miR-486-5p Regulates Cell Cycle, Proliferation and Metastasis in Lung Adenocarcinoma via Targeting NEK2. Frontiers in Bioengineering and Biotechnology 2020; 8 doi: 10.3389/fbioe.2020.00259
|
| 5 |
Jiamei Zhang, Huihui Sun, KunXiu Jiang, Xingzhuo Song, Xirui Wang, Yuqian Yang, Hanying Liu, Qingxuan Ji, Xue Yu, Yonggang Liu, Jing Han, Wei Wang. Cudraxanthone L inhibits gastric cancer by regulating the MAPK signalling and promoting FAS-mediated pathway. Biomedicine & Pharmacotherapy 2021; 141: 111876 doi: 10.1016/j.biopha.2021.111876
|
| 6 |
Jianyong Wu, Desheng Luo, Laizhen Tou, Hongtao Xu, Chuan Jiang, Dan Wu, Haifeng Que, Jingjing Zheng. NEK2 affects the ferroptosis sensitivity of gastric cancer cells by regulating the expression of HMOX1 through Keap1/Nrf2. Molecular and Cellular Biochemistry 2024; doi: 10.1007/s11010-024-04960-y
|
| 7 |
Zeyu Xing, Menglu Zhang, Xin Wang, Jiaqi Liu, Gang Liu, Kexin Feng, Xiang Wang. Silencing of Nek2 suppresses the proliferation, migration and invasion and induces apoptosis of breast cancer cells by regulating ERK/MAPK signaling. Journal of Molecular Histology 2021; 52(4): 809 doi: 10.1007/s10735-021-09979-9
|
| 8 |
Ewelina Motylewska, Marcin Braun, Henryk Stępień. High Expression of NEK2 and PIM1, but Not PIM3, Is Linked to an Aggressive Phenotype of Bronchopulmonary Neuroendocrine Neoplasms. Endocrine Pathology 2020; 31(3): 264 doi: 10.1007/s12022-020-09629-y
|
| 9 |
Yue Zhang, Man Yan, Yongjun Yu, Jiangping Wang, Yuqi Jiao, Minying Zheng, Shiwu Zhang. 14–3-3ε: a protein with complex physiology function but promising therapeutic potential in cancer. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-023-01420-w
|
| 10 |
Xuemei Zeng, Juan Xiao, Xue Bai, Yiwen Liu, Meilan Zhang, Jiangrong Liu, Zixuan Lin, Zhiwei Zhang. Research progress on the circRNA/lncRNA-miRNA-mRNA axis in gastric cancer. Pathology - Research and Practice 2022; 238: 154030 doi: 10.1016/j.prp.2022.154030
|
| 11 |
Yao Cheng, Xinyan Yang, Lichun Liang, Hua Xin, Xinyu Dong, Weidong Li, Jie Li, Xiaoli Guo, Yue Li, Jian He, Chunbin Zhang, Weiqun Wang. Elevated expression of CXCL3 in colon cancer promotes malignant behaviors of tumor cells in an ERK-dependent manner. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11655-y
|
| 12 |
Hao Wan, Lin Xu, Huangbin Zhang, Feixiang Wu, Weiqiang Zeng, Taiyuan Li. High expression of NEK2 promotes gastric cancer progression via activating AKT signaling. Journal of Physiology and Biochemistry 2021; 77(1): 25 doi: 10.1007/s13105-020-00776-8
|
| 13 |
Xing Huang, Gang Zhang, Tianyu Tang, Xiang Gao, Tingbo Liang. One shoot, three birds: Targeting NEK2 orchestrates chemoradiotherapy, targeted therapy, and immunotherapy in cancer treatment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(2): 188696 doi: 10.1016/j.bbcan.2022.188696
|
| 14 |
Jingjing Liu, Zhenwei Tian, Tianzhou Liu, Dacheng Wen, Zhiming Ma, Yuanda Liu, Jiaming Zhu. CHSY1 is upregulated and acts as tumor promotor in gastric cancer through regulating cell proliferation, apoptosis, and migration. Cell Cycle 2021; 20(18): 1861 doi: 10.1080/15384101.2021.1963553
|